NATCO PHARMA LTD.
NATCOPHARM.NS
₹ 1,363.70
1%
Natco Pharma Ltd
Natco Pharma Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of NATCO Pharma is ₹ 1,363.70 that is ₹ 11.05 -0.8% with respect to the previous day’s close price. The stock price of NATCO Pharma was last updated 4 seconds ago.
NATCO Pharma Stock Price Performance
In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.
NATCO Pharma Live Share Price Analysis
NATCO PHARMA LTD.
₹ 1,363.70
Open ₹ 1,379.80
High ₹ 1,386.40
Marketcap 244.52B
Close ₹ 1,363.70
Low ₹ 1,359.35
Volume ₹ 107,853.00
The stock of Natco Pharma Ltd strated the trade at an Open price of ₹ 1,379.80 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 1,386.40 and an Intraday Low price of ₹ 1,359.35%. As per last updated 4 seconds ago, the Shares of NATCO Pharma were trading at a price of ₹ 1,363.70 which is ₹ 11.05 -0.8% as compared the price ₹ 1,374.75 at which the stock close on the previous trading day. The total traded volume for the day stood at 107,853 number of shares.
Candlestick Chart of NATCO Pharma Share Price Movements
The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).
Historical Performance of NATCO Pharma Shares
| 52 Week Range | Price | 52 Weeks Low | 52 Weeks High |
|---|---|---|---|
| ₹ 1,363.70 | ₹ 752.45 | ₹ 1,639.00 |
Here is NATCO Pharma’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 1,639.00. On the lower side, the stock has been to the 52 weeks low price level of ₹ 752.45. It’s last traded price was ₹ 1,363.70 as on last update 5 seconds ago. The one-year line chart clearly shows how the price of NATCO Pharma’s stock has moved in the last twelve months.
The Company has posted an earnings of ₹ 108.61 per share (EPS TTM) in the trailing twelve months period. NATCO Pharma’s last annual dividend rate was 5.75%, which translates to a 0.42% of annual dividend yield.
Line Chart of NATCO Pharma Stock Price
Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.
Companies Similar to NATCO Pharma
Natco Pharma Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to NATCO Pharma are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.
Share Price Snapshot Companies Similar to NATCO Pharma
Select list of companies is given below. To view more about the Industry and see other companies from Pharmaceuticals & Drugs Industry, click on the industry name.
About NATCO Pharma
Natco Pharma Ltd is a Natco Group Company. The company operates in the Pharmaceuticals & Drugs sector. It is a pharmaceutical company. Incorporated in 1981, it has around 40 years of operations. NATCO Pharma live share price is ₹ 1,363.70. It is a Small Cap stock and had a market capitalization of ₹ 244,520,960,000.00 as on 5 seconds ago.
- NATCO Pharma is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).
- The Company’s segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others.
- The Company’s product categories include Domestic Formulations, International Formulations, API’s and Blockbusters.
- The Company’s products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate.
- The Company manufactures over 20 products under contract.
The registered office of NATCO Pharma is located in Hyderabad, Telangana. The registrar and share transfer agent for NATCO Pharma is Venture Capital & Corporate Investments Ltd. The Stock Exchanges on which shares of Natco Pharma Ltd is listed includes BSE, NSE, MCX.
NATCO PHARMA LTD.
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 4016
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
| Address | Natco House, Hyderabad, India |
| Country | India |
| Phone | 91 40 2354 7532 |
| Website | https://www.natcopharma.co.in |
NATCO Pharma Recent News
No Recent News found for Natco Pharma Ltd.